Phibro Animal Health Corporation (Nasdaq: PAHC) has confirmed that its senior executive leadership team will present a comprehensive update on the company’s international product portfolios at the Stifel 2026 Jaws & Paws Conference in New York City on Wednesday, May 27, 2026.
The briefing will be led by Daniel Bendheim, Executive Vice President of Corporate Strategy and CEO Designate, who is preparing to assume the chief executive role on July 1, 2026. Joining him on the panel will be Chief Operating Officer Larry Miller and Chief Financial Officer Glenn David.
Capitalizing on Q3 Financial Growth
The upcoming investor presentation follows Phibro’s strong fiscal Q3 2026 performance, which reported a 10% year-over-year increase in consolidated net sales to US$383.5 million.
Company executives are expected to emphasize the performance of Phibro’s core Animal Health Segment, which generated US$291.2 million in quarterly revenue (up 13%). This momentum was primarily driven by:
-
A 16% global volume expansion across its proprietary livestock vaccine lines.
-
A 25% revenue surge within its newly integrated, ex-Zoetis Medicated Feed Additives (MFA) portfolio.
Mitigating Structural and Regulatory Headwinds
Wall Street analysts anticipate that the leadership team will use the forum to directly address recent stock volatility and layout strategic counters to ongoing international headwinds:
-
The Brazilian Regulatory Pivot: Executives will outline Phibro’s compliance framework regarding Brazil’s Ordinance No. 1617, which bans growth-promotion claims for veterinary antimicrobials like virginiamycin. Phibro is currently in the final stages of shifting to therapeutic-only re-registrations and is deploying its PhibroVet® digital prescription platform to preserve market share
-
The Sustainable Solutions Rollout: The team will present commercialization timelines for its newly launched Sustainable Solutions Platform (SSP). Anchored by a strategic partnership with VAXA Technologies, the initiative introduces VERRATAIN™—a master brand of low-carbon, microalgae-based feed ingredients (including specialized Spirulina and Omega Oils) designed to help multinational protein producers aggressively reduce Scope 3 supply chain emissions
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.
